The incidence of NF2 mutations in our cohort is markedly higher than what is reported in ccRCC (0–1%)10, 11, 20, pRCC (0–6%)15, 16, 17 and chRCC (0%)14, 15. Here, NF2 is linked to nonpapillary renal cell carcinoma.